Picture Consultech GmbH Secure Funding with RnD Grants v7 650x100px
Document › Details

MorphoSys AG. (5/3/23). "Press Release: MorphoSys AG Reports First Quarter 2023 Financial Results". Planegg.

Organisations Organisation MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; Nasdaq: MOR)
  Group Novartis (Group)
  Organisation 2 Incyte Corporation (Nasdaq: INCY)
  Group Incyte Corporation (Group)
Products Product Minjuvi® / Monjuvi®
  Product 2 pelabresib (CPI-0610)
Persons Person Kress, Jean-Paul (MorphoSys 201909–202406 CEO before Syntimmune + Biogen + Sanofi Genzyme TERMINATED 6/26)
  Person 2 Crabtree, Lucinda (Lucy) (Oxford Biomedica 202409– CFO before MorphoSys + Autolus + Woodford Investment)

Record changed: 2024-01-20


Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x200px

More documents for Novartis (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group World of Partnering Opportunities 650x300px

» top